FDA Approves Wireless Glucose Monitoring System
The Food and Drug Administration approved a wireless glucose monitoring device built by Dexcom, which uses Bluetooth to transmit data from the on-person monitor to an app on iOS-enabled devices, the company said in news releases Monday and Tuesday. The…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
G5 Mobile Continuous Glucose Monitoring System allows users to share their glucose information with up to five recipients, who can then remotely monitor the patient's information and receive mobile alerts, Dexcom said. The company previously introduced the G4 glucose monitor and apps for use on the Apple Watch, it said, and expects to begin shipping G5 devices in late September. Dexcom also said it plans to release an Android app for the G5 device in early 2016.